Cancer Letters

Article	Citations
CD155 in tumor progression and targeted therapy	292
The tumor microenvironment's role in malignant progression and treatment response	288
TD-92, a novel erlotinib derivative, depletes tumor-associated macrophages in non-small cell lung cancer via down-regulation of CSF-1R and enhances the anti-tumor effects of anti-PD-1	244
IGFBP7-AS1 is a p53-responsive long noncoding RNA downregulated by Epstein-Barr virus that contributes to viral tumorigenesis	226
NEAT1 Promotes the Perineural Invasion of Pancreatic Cancer via the E2F1/GDNF Axis	212
Selpercatinib mitigates cancer cachexia independent of anti-tumor activity in the HT1080 tumor model	207
Enhancing cancer radiotherapy efficacy using NanOx, a novel oxygenating perfluorocarbon nanoemulsion that reverses tumour hypoxia	181
Nervous system in colorectal cancer	134
Corrigendum to “HIF-2α 1 inhibition disrupts leukemia stem cell metabolism and impairs vascular microenvironment to enhance chronic myeloid leukemia treatment” [Cancer lett. 597 (2024) 217060]	130
An emerging aspect of cancer neuroscience: A literature review on chemotherapy-induced peripheral neuropathy	130
Tumor-derived exosomes: Unravelling the pathogenesis of pancreatic cancer with liver metastases and exploring the potential for clinical translation	124
Molecular mechanisms and genetic alterations in prostate cancer: From diagnosis to targeted therapy	122
ASPH dysregulates cell death and induces chemoresistance in hepatocellular carcinoma	122
Isthmin-1 promotes growth and progression of colorectal cancer through the interaction with EGFR and YBX-1	112
KAT7 enhances the proliferation and metastasis of head and neck squamous carcinoma by promoting the acetylation level of LDHA	106
lncRNA LINC01057 promotes mesenchymal differentiation by activating NF-κB signaling in glioblastoma	105
NLRP3-activated bone marrow dendritic cells play antileukemic roles via IL-1β/Th1/IFN-γ in acute myeloid leukemia	102
Epigenetic silencing of chemokine CCL2 represses macrophage infiltration to potentiate tumor development in small cell lung cancer	102
The opportunities and challenges of using PD-1/PD-L1 inhibitors for leukemia treatment	100
Tumor-associated macrophages drive glycolysis through the IL-8/STAT3/GLUT3 signaling pathway in pancreatic cancer progression	97
Colorectal cancer immunotherapy-Recent progress and future directions	96
EZH2 and NF-κB: A context-dependent crosstalk and transcriptional regulation in cancer	96
METTL3 promotes pancreatic cancer proliferation and stemness by increasing stability of ID2 mRNA in a m6A-dependent manner	94
Enzalutamide-induced and PTH1R-mediated TGFBR2 degradation in osteoblasts confers resistance in prostate cancer bone metastases	90
Direct contact between tumor cells and platelets initiates a FAK-dependent F3/TGF-β positive feedback loop that promotes tumor progression and EMT in osteosarcoma	86

Non-coding RNA derived from extracellular vesicles in cancer immune escape: Biological functions and potential clinical applications	84
CD24 promotes metastasis and chemoresistance by directly targeting Arf6-ERK pathway in esophageal squamous cell carcinoma	84
Skin cancer prevention – Recent advances and unmet challenges	81
Targeted inhibition of the expression of both MCM5 and MCM7 by miRNA-214 impedes DNA replication and tumorigenesis in hepatocellular carcinoma cells	81
AMPK-mediated CD47 H3K4 methylation promotes phagocytosis evasion of glioma stem cells post-radiotherapy	81
Metronomic chemotherapy regimens and targeted therapies in non-Hodgkin lymphoma: The best of two worlds	80
Lysophosphatidic acid-induced amphiregulin secretion by cancer-associated fibroblasts augments cancer cell invasion	75
Anaplastic thyroid cancer cells upregulate mitochondrial one-carbon metabolism to meet purine demand, eliciting a critical targetable vulnerability	72
A natural compound melatonin enhances the effects of Nimotuzumab via inhibiting EGFR in glioblastoma	71
Osteosarcoma exocytosis of soluble LGALS3BP mediates macrophages toward a tumoricidal phenotype	71
Precision intervention for prostate cancer: Re-evaluating who is at risk	71
Editorial Board	70
FOSL2 promotes intertumoral infiltration of T cells and increases pathological complete response rates in locally advanced rectal cancer patients	69
Editorial Board	67
Response to the Letter to the editor regarding “Targeting NUPR1 with the small compound ZZW-115 is an efficient strategy to treat hepatocellular carcinoma” by Jiong Lin	66
Editorial Board	66
Lymphocyte antigen 6K signaling to aurora kinase promotes advancement of the cell cycle and the growth of cancer cells, which is inhibited by LY6K-NSC243928 interaction	65
Editorial Board	65
Editorial Board	62
Editorial Board	62
PA suppresses antitumor immunity of T cells by disturbing mitochondrial activity through Akt/mTOR-mediated Ca2+ flux	62
Editorial Board	61
EphB1 promotes the differentiation and maturation of dendritic cells in non-small cell lung cancer	60
Single-cell transcriptome profiling of primary tumors and paired organoids of pancreatobiliary cancer	59
Potential Contribution of Ovarian Granulosa Cells to High-Grade Serous Ovarian Cancer Development	59
NOS2 and COX2 predicts poor outcome in ER- breast cancer through immunosuppression. Novel Strategies to overcome immunosuppression	59
Ethnic Diversity and Metabolic Variations in Ovarian Cancer Cells: Implications for Personalized Medicine Strategies	58
Precision cancer medicine in ovarian cancer	58
Lysine demethylase KDM1A/LSD1 inhibition enhances estrogen receptor beta-mediated tumor suppression in ovarian cancer	58
Bypassing the Tollway; a novel path to TLR4 independent stemness regulation	58
Aberrant Translational Mechanisms in Cancer Cells	57
Oxysterol-Sterol Binding Proteins as Druggable Precision Targets in Ovarian Cancer	57
Neuro-immune communication in breast cancer	57
JC-010a, a novel selective SHP2 allosteric inhibitor, overcomes RTK/non-RTK-mediated drug resistance in multiple oncogene-addicted cancers	55
Versatility of Exosomes for Cancer Therapy	55
Exosomal lncCRLA is predictive for the evolvement and development of lung adenocarcinoma	55
Extrinsic factors associated with the response to immunotherapy in glioblastoma	55
Electrochemical Immunosensor for the Detection of Circulating Tumor Cells.	55
Colorectal cancer risk variant rs7017386 modulates two oncogenic lncRNAs expression via ATF1-mediated long-range chromatin loop	54
Editorial Board	54
Understanding cervical cancer at single-cell resolution	54
Editorial Board	53
Letter to the editor regarding “EBV-LMP1 suppresses the DNA damage response through DNA-PK/AMPK signaling to promote radioresistance in nasopharyngeal carcinoma”	53
Editorial Board	53
Coiled-coil domain-containing 154 promotes colorectal cancer proliferation and metastasis via interacting with minichromosome maintenance complex component 2	53
Editorial Board	53
Loss of CD73 shifts transforming growth factor-β1 (TGF-β1) from tumor suppressor to promoter in endometrial cancer	52
Miz1 promotes KRAS-driven lung tumorigenesis by repressing the protocadherin Pcdh10	52
The role of Hippo/YAP1 in cancer-associated fibroblasts: Literature review and future perspectives	51
Cooperation between IRTKS and deubiquitinase OTUD4 enhances the SETDB1-mediated H3K9 trimethylation that promotes tumor metastasis via suppressing E-cadherin expression	51

Increasing membrane polyunsaturated fatty acids sensitizes non-small cell lung cancer to anti-PD-1/PD-L1 immunotherapy	51
Sulforaphane suppresses bladder cancer metastasis via blocking actin nucleation-mediated pseudopodia formation	51
The deubiquitinase OTUD5 stabilizes SLC7A11 to promote progression and reduce paclitaxel sensitivity in triple-negative breast cancer	50
Exosomes; multifaceted nanoplatform for targeting brain cancers	50
Extracellular vesicles in the tumor immune microenvironment	49
Jolkinolide B sensitizes bladder cancer to mTOR inhibitors via dual inhibition of Akt signaling and autophagy	49
Recent advancement of autophagy in polyploid giant cancer cells and its interconnection with senescence and stemness for therapeutic opportunities	49
Targeting the mercapturic acid pathway for the treatment of melanoma	48
TGF-β signaling networks in the tumor microenvironment	48
Acquired resistance to BRAF inhibitors is mediated by BRAF splicing variants in BRAF V600E mutation-positive colorectal neuroendocrine carcinoma	48
Long term outcome of prevention of liver cancer by hepatitis B vaccine: Results from an RCT with 37 years	47
TCR-induced FOXP3 expression by CD8+ T cells impairs their anti-tumor activity	47
KRAS-dependent cancer cells promote survival by producing exosomes enriched in Survivin	47
Olaparib enhances radiation-induced systemic anti-tumor effects via activating STING-chemokine signaling in hepatocellular carcinoma	47
Understanding the significance of biological clock and its impact on cancer incidence	46
Engineering nanomedicines to inhibit hypoxia-inducible Factor-1 for cancer therapy	46
PARP inhibitor plus radiotherapy reshapes an inflamed tumor microenvironment that sensitizes small cell lung cancer to the anti-PD-1 immunotherapy	45
Regulation of metabolism in pancreatic ductal adenocarcinoma via nanotechnology-enabled strategies	45
Tumor-targeted exosomes for delivery of anticancer drugs	45
Is it time to discard the Diagnostic and Statistical Manual of Mental Disorders (DSM) in psycho-oncology?	45
Colorectal cancer-associated fibroblasts inhibit effector T cells via NECTIN2 signaling	45
CSNK2A1 confers gemcitabine resistance to pancreatic ductal adenocarcinoma via inducing autophagy	44
Combinations of ivermectin with proteasome inhibitors induce synergistic lethality in multiple myeloma	44
Repositioning of mifepristone as an integrated stress response activator to potentiate cisplatin efficacy in non-small cell lung cancer	44
USP7-mediated ERβ stabilization mitigates ROS accumulation and promotes osimertinib resistance by suppressing PRDX3 SUMOylation in non-small cell lung carcinoma	44
Axl as a potential therapeutic target for adamantinomatous craniopharyngiomas: Based on single nucleus RNA-seq and spatial transcriptome profiling	43
Palmitoylation alters LDHA activity and pancreatic cancer response to chemotherapy	43
Precise delivery of celastrol by PEGylated aptamer dendrimer nanoconjugates for enormous therapeutic effect via superior intratumor penetration over antibody counterparts	43
Metronomic chemotherapy as a potential partner of immune checkpoint inhibitors for metastatic colorectal cancer treatment	43
Thermal-sensitive lipid nanoparticles potentiate anti-PD therapy through enhancing drug penetration and T lymphocytes infiltration in metastatic tumor	42
Targeted therapy, immunotherapy, and small molecules and peptidomimetics as emerging immunoregulatory agents for melanoma	42
Poly-pharmacology of existing drugs: How to crack the code?	42
Biological, diagnostic and therapeutic implications of exosomes in glioma	42
Targeted inhibition of acidic nucleoplasmic DNA-binding protein 1 enhances radiosensitivity of non-small cell lung cancer	42
Immune checkpoints between epithelial-mesenchymal transition and autophagy: A conflicting triangle	42
The GPER1/SPOP axis mediates ubiquitination-dependent degradation of ERα to inhibit the growth of breast cancer induced by oestrogen	41
Intracellular AGR2 transduces PGE2 stimuli to promote epithelial–mesenchymal transition and metastasis of colorectal cancer	41
Nanosecond pulsed electric field stimulates CD103+ DC accumulation in tumor microenvironment via NK-CD103+ DC crosstalk	40
Editorial Board	40
FGFR1/MAPK-directed brachyury activation drives PD-L1-mediated immune evasion to promote lung cancer progression	40
Pharmacological approaches for targeting lysosomes to induce ferroptotic cell death in cancer	40
MDSCs in bone metastasis: Mechanisms and therapeutic potential	40
The stromal microenvironment endows pancreatic neuroendocrine tumors with spatially specific invasive and metastatic phenotypes	40
Coupling HDAC4 with transcriptional factor MEF2D abrogates SPRY4-mediated suppression of ERK activation and elicits hepatocellular carcinoma drug resistance	39
A unique circulating microRNA pairs signature serves as a superior tool for early diagnosis of pan-cancer	39
Induction of EnR stress by Melatonin enhances the cytotoxic effect of Lapatinib in HER2-positive breast cancer	39
Phosphorylation of intestine-specific homeobox by ERK1 modulates oncogenic activity and sorafenib resistance	39
CRISPR/Cas9 screenings unearth protein arginine methyltransferase 7 as a novel essential gene in prostate cancer metastasis	39
Sex differences in health and disease: A review of biological sex differences relevant to cancer with a spotlight on glioma	39
Neoadjuvant chemotherapy-induced remodeling of human hormonal receptor-positive breast cancer revealed by single-cell RNA sequencing	39
Investigating autophagy and intricate cellular mechanisms in hepatocellular carcinoma: Emphasis on cell death mechanism crosstalk	38
Enhanced AC133-specific CAR T cell therapy induces durable remissions in mice with metastatic small cell lung cancer	38
Tumor-associated mesenchymal stem cells promote hepatocellular carcinoma metastasis via a DNM3OS/KDM6B/TIAM1 axis	38
Oncolytic virus-based combination therapy in breast cancer	38
Sublethal heat stress-induced O-GlcNAcylation coordinates the Warburg effect to promote hepatocellular carcinoma recurrence and metastasis after thermal ablation	37
Super-enhancer mediated upregulation of MYEOV suppresses ferroptosis in lung adenocarcinoma	37
Dual blockade of EGFR and CDK4/6 delays head and neck squamous cell carcinoma progression by inducing metabolic rewiring	37
Ubiquitin-specific peptidase 22 in cancer	37
Circular RNA circTATDN3 promotes the Warburg effect and proliferation in colorectal cancer	37
CD147-specific chimeric antigen receptor T cells effectively inhibit T cell acute lymphoblastic leukemia	37
Sunitinib increases the cancer stem cells and vasculogenic mimicry formation via modulating the lncRNA-ECVSR/ERβ/Hif2-α signaling	37
CXCL13 promotes intestinal tumorigenesis through the activation of epithelial AKT signaling	37
Pioneering the future of cancer therapy: Deciphering the p53-ferroptosis nexus for precision medicine	37
circVAPA-rich small extracellular vesicles derived from gastric cancer promote neural invasion by inhibiting SLIT2 expression in neuronal cells	36
Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma therapy: Challenges and opportunities	36
Novel EGFR-mutant mouse models of lung adenocarcinoma reveal adaptive immunity requirement for durable osimertinib response	36
RBBP4 regulates the expression of the Mre11-Rad50-NBS1 (MRN) complex and promotes DNA double-strand break repair to mediate glioblastoma chemoradiotherapy resistance	36
Exosome-mediated transfer of SNHG7 enhances docetaxel resistance in lung adenocarcinoma	36
Tuning cellular metabolism for cancer virotherapy	36
A novel antagonist of the CCL5/CCR5 axis suppresses the tumor growth and metastasis of triple-negative breast cancer by CCR5-YAP1 regulation	36
Inhibition of ribonucleotide reductase subunit M2 enhances the radiosensitivity of metastatic pancreatic neuroendocrine tumor	35
Inositol hexaphosphate enhances chemotherapy by reversing senescence induced by persistently activated PERK and diphthamide modification of eEF2	35
Anlotinib synergizes with venetoclax to induce mitotic catastrophe in acute myeloid leukemia	35
Proteasome inhibitors suppress MYB oncogenic activity in a p300-dependent manner	35
Single-cell transcriptomics reveals the aggressive landscape of high-grade serous carcinoma and therapeutic targets in tumor microenvironment	35
Disrupting PHF8-TOPBP1 connection elicits a breast tumor-specific vulnerability to chemotherapeutics	35
TKI resistant-based prognostic immune related gene signature in LUAD, in which FSCN1 contributes to tumor progression	35
Preoperative neoadjuvant targeted therapy remodels intra-tumoral heterogeneity of clear-cell renal cell carcinoma and ferroptosis inhibition induces resistance progression	35
Maternal embryonic leucine zipper kinase in tumor cells and tumor microenvironment: An emerging player and promising therapeutic opportunity	35
Gene knockout in cellular immunotherapy: Application and limitations	34

Mechanisms used by cancer cells to tolerate drug-induced replication stress	34
METTL3 regulates M6A methylation-modified EBV-pri-miR-BART3-3p to promote NK/T cell lymphoma growth	34
HOXA5 is amplified in glioblastoma stem cells and promotes tumor progression by transcriptionally activating PTPRZ1	34
PD-1 regulation in immune homeostasis and immunotherapy	34
Inhibition of ribosomal RNA processing 15 Homolog (RRP15), which is overexpressed in hepatocellular carcinoma, suppresses tumour growth via induction of senescence and apoptosis	34
TNPO1-mediated nuclear import of ARID1B promotes tumor growth in ARID1A-deficient gynecologic cancer	33
The past, present, and future of liver cancer research in China	33
Valproate and lithium: Old drugs for new pharmacological approaches in brain tumors?	33
A new miRNA-Modified coxsackievirus B3 inhibits triple negative breast cancer growth with improved safety profile in immunocompetent mice	33
Macrophages are primed to transdifferentiate into fibroblasts in malignant ascites and pleural effusions	33
ETS-related gene (ERG) undermines genome stability in mouse prostate progenitors via Gsk3β dependent Nkx3.1 degradation	33
Unveiling major histocompatibility complex-mediated pan-cancer immune features by integrated single-cell and bulk RNA sequencing	33
Mechanistic insights into genetic susceptibility to prostate cancer	33
The E3 ligase TRIM22 functions as a tumor suppressor in breast cancer by targeting CCS for proteasomal degradation to inhibit STAT3 signaling	33
A novel promoter-associated non-coding small RNA paGLI1 recruits FUS/P65 to transactivate GLI1 gene expression and promotes infiltrating glioma progression	32
Cervical cancer burden, status of implementation and challenges of cervical cancer screening in Association of Southeast Asian Nations (ASEAN) countries	32
PI3K inhibitor impairs tumor progression and enhances sensitivity to anlotinib in anlotinib-resistant osteosarcoma	32
Exosomal long non-coding RNAs in the diagnosis and oncogenesis of pancreatic cancer	32
c-Myc-activated intronic miR-210 and lncRNA MIR210HG synergistically promote the metastasis of gastric cancer	32
IL-1α facilitates GSH synthesis to counteract oxidative stress in oral squamous cell carcinoma under glucose-deprivation	31
ERBB3 targeting: A promising approach to overcoming cancer therapeutic resistance	31
Targeting lipid metabolism is an emerging strategy to enhance the efficacy of anti-HER2 therapies in HER2-positive breast cancer	31
Peroxiredoxin 1 is essential for natamycin-triggered apoptosis and protective autophagy in hepatocellular carcinoma	31
The diverse pancreatic tumor cell-intrinsic response to IFNγ is determined by epigenetic heterogeneity	31
Editorial Board	31
IBI379, a novel B cell maturation antigen/CD3 bispecific T-cell engager, displays high antitumor efficacy in preclinical models of multiple myeloma	30
A small molecule targeting the interaction between human papillomavirus E7 oncoprotein and cellular phosphatase PTPN14 exerts antitumoral activity in cervical cancer cells	30
Clinical challenges in prostate cancer management: Metastatic bone-tropism and the role of circulating tumor cells	30
Cancer-initiating cells in human pancreatic cancer organoids are maintained by interactions with endothelial cells	30
Chidamide and mitomycin C exert synergistic cytotoxic effects against bladder cancer cells in vitro and suppress tumor growth in a rat bladder cancer model	30
Immune checkpoint inhibitors as first-line treatment for brain metastases in stage IV NSCLC patients without driver mutations	30
SETD8 stabilized by USP17 epigenetically activates SREBP1 pathway to drive lipogenesis and oncogenesis of ccRCC	30
ACLP promotes activation of cancer-associated fibroblasts and tumor metastasis via ACLP-PPARγ-ACLP feedback loop in pancreatic cancer	30
CAPN2-responsive mesoporous silica nanoparticles: A promising nanocarrier for targeted therapy of pancreatic cancer	30
Unravelling the biological and clinical challenges of circulating tumour cells in epithelial ovarian carcinoma	30
Editorial Board	29
DIAPH1 mutations predict a favorable outcome for de novo MDS	29
Editorial Board	29
Electroacupuncture facilitates vascular normalization by inhibiting Glyoxalase1 in endothelial cells to attenuate glycolysis and angiogenesis in triple-negative breast cancer	29
Secretory Trefoil Factor 1 (TFF1) promotes gemcitabine resistance through chemokine receptor CXCR4 in Pancreatic Ductal Adenocarcinoma	29
M6A-modified lncRNA FAM83H-AS1 promotes colorectal cancer progression through PTBP1	29
Irradiated tumor cell-released microparticles enhance the therapeutic efficacy of PD-1 inhibitors by promoting M1-TAMs polarization in NSCLC brain metastases	29
Periodontitis is an immune-related adverse event associated with immune checkpoint inhibitors: A multi-center cohort study	29
LncRNAs and the cancer epigenome: Mechanisms and therapeutic potential	29
Histone deacetylase upregulation of neuropilin-1 in osteosarcoma is essential for pulmonary metastasis	29
Intratumoral injection of mRNA encoding survivin in combination with STAT3 inhibitor stattic enhances antitumor effects	29
Targeting LSD1 in cancer: Molecular elucidation and recent advances	29
Biphasic co-detection of melanoma aneuploid tumor cells and tumor endothelial cells in guidance of specifying the field cancerized surgical excision margin and administering immunotherapy	29
Pirfenidone antagonizes TGF-β1-mediated gabapentin resistance via reversal of desmoplasia and the ‘cold’ microenvironment in pancreatic cancer	29
Consensus on the monitoring, treatment, and prevention of leukaemia relapse after allogeneic haematopoietic stem cell transplantation in China: 2024 update	28
EZH2 inhibition confers PIK3CA-driven lung tumors enhanced sensitivity to PI3K inhibition	28
Survival benefit and spatial properties of tertiary lymphoid structures in esophageal squamous cell carcinoma with neoadjuvant therapies	28
PAK4 inhibition improves PD1 blockade immunotherapy in prostate cancer by increasing immune infiltration	28
Blockade of the lncRNA-PART1-PHB2 axis confers resistance to PARP inhibitor and promotes cellular senescence in ovarian cancer	28
Evaluation of glucocorticoid-related genes reveals GPD1 as a therapeutic target and regulator of sphingosine 1-phosphate metabolism in CRPC	28
Fascin promotes lung cancer growth and metastasis by enhancing glycolysis and PFKFB3 expression	28
Reuterin promotes pyroptosis in hepatocellular cancer cells through mtDNA-mediated STING activation and caspase 8 expression	28
Combination treatment with 17β-estradiol and anti-PD-L1 suppresses MC38 tumor growth by reducing PD-L1 expression and enhancing M1 macrophage population in MC38 colon tumor model	28
Fibrillarin reprograms glucose metabolism by driving the enhancer-mediated transcription of PFKFB4 in liver cancer	28
ATR inhibition amplifies antitumor effects of olaparib in biliary tract cancer	28
Unveiling the veil of RNA binding protein phase separation in cancer biology and therapy	28
A complex of Wnt/planar cell polarity signaling components Vangl1 and Fzd7 drives glioblastoma multiforme malignant properties	28
YBX1 as a therapeutic target to suppress the LRP1-β-catenin-RRM1 axis and overcome gemcitabine resistance in pancreatic cancer	28
Improvement strategy for immune checkpoint blockade: A focus on the combination with immunogenic cell death inducers	27
TRIM29 promotes antitumor immunity through enhancing IGF2BP1 ubiquitination and subsequent PD-L1 downregulation in gastric cancer	27
Acidosis-induced regulation of adipocyte G0S2 promotes crosstalk between adipocytes and breast cancer cells as well as tumor progression	27
Biological characteristics of pancreatic ductal adenocarcinoma: Initiation to malignancy, intracellular to extracellular	27
LW-213 induces immunogenic tumor cell death via ER stress mediated by lysosomal TRPML1	27
METTL3-m6A-EGFR-axis drives lenvatinib resistance in hepatocellular carcinoma	27
Targeting STAT3 potentiates CDK4/6 inhibitors therapy in head and neck squamous cell carcinoma	27
LncRNA PWRN1 inhibits the progression of hepatocellular carcinoma by activating PKM2 activity	27
Worldwide distribution, associated factors, and trends of gallbladder cancer: A global country-level analysis	27
DNMT and EZH2 inhibitors synergize to activate therapeutic targets in hepatocellular carcinoma	27
Pleckstrin-2 promotes tumour immune escape from NK cells by activating the MT1-MMP-MICA signalling axis in gastric cancer	27
Linking cell-surface GRP78 to cancer: From basic research to clinical value of GRP78 antibodies	27
A three-stage eccDNA based molecular profiling significantly improves the identification, prognosis assessment and recurrence prediction accuracy in patients with glioma	27
Incidence, mortality, survival, risk factor and screening of colorectal cancer: A comparison among China, Europe, and northern America	27
Pericytes in the tumor microenvironment	26
Small extracellular vesicles containing miR-192/215 mediate hypoxia-induced cancer-associated fibroblast development in head and neck squamous cell carcinoma	26
Fueling immune checkpoint blockade with oncolytic viruses: Current paradigms and challenges ahead	26
DT7 peptide-modified lecithin nanoparticles co-loaded with γ-secretase inhibitor and dexamethasone efficiently inhibit T-cell acute lymphoblastic leukemia and reduce gastrointestinal toxicity	26
Tissue factor overexpression in triple-negative breast cancer promotes immune evasion by impeding T-cell infiltration and effector function	26
Hepatocellular carcinoma and lipid metabolism: Novel targets and therapeutic strategies	26
TOX-expressing terminally exhausted tumor-infiltrating CD8+ T cells are reinvigorated by co-blockade of PD-1 and TIGIT in bladder cancer	26
Multi-targeted therapy of cancer by omega-3 fatty acids-an update	26
Cross-talk between BCKDK-mediated phosphorylation and STUB1-dependent ubiquitination degradation of BCAT1 promotes GBM progression	26
The interplay between autophagy and apoptosis: its implication in lung cancer and therapeutics	26
Immune checkpoint inhibitor resistance in hepatocellular carcinoma	26
Metabolic reprogramming by ex vivo glutamine inhibition endows CAR-T cells with less-differentiated phenotype and persistent antitumor activity	26
RNF144A deficiency promotes PD-L1 protein stabilization and carcinogen-induced bladder tumorigenesis	26
Carboxypeptidase E and its splice variants: Key regulators of growth and metastasis in multiple cancer types	26
Fundamental insights and molecular interactions in pancreatic cancer: Pathways to therapeutic approaches	25
Reprogramming of TAMs via the STAT3/CD47-SIRPα axis promotes acquired resistance to EGFR-TKIs in lung cancer	25
EMP3 as a key downstream target of miR-663a regulation interferes with MAPK/ERK signaling pathway to inhibit gallbladder cancer progression	25
Fatty acids in cancer chemoresistance	25